Fortecor 5 mg for dogs 5-20 kg and cats 2.5-10 kg, 14 tablets
OR
Fortecor 20 mg for dogs weighing 21-80 kg, 14 tablets
COMPOSITION AND FORM OF ISSUE
Fortecor tablets 5 mg contain benazepril hydrochloride as an active ingredient - 5 mg / table. as well as auxiliary substances: microcrystalline cellulose - 19%, crospovidone - 5%, silicon colloidal anhydride - 0.5%, stearic acid - 3%, dry yeast and beef flavor additive - 60%. Fortecor ™ tablets are produced in blisters, packed in cardboard boxes.
Fortecor tablets 20 mg contain benazepril hydrochloride as an active ingredient - 20 mg / tab., As well as auxiliary substances: microcrystalline cellulose - 2.93%, crospovidone - 5%, silicon colloidal anhydride - 0.5%, stearic acid - 3% , dry yeast and beef flavor additive - 60%. Fortecor ™ tablets are produced in blisters, packed in cardboard boxes.
PHARMACOLOGICAL PROPERTIES
Fortecor ™ is an ACE inhibitor. Benazepril hydrochloride, which is part of the drug, as a result of hydrolysis forms the active metabolite benazeprilat, which inhibits the angiotensin converting enzyme (ACE). This enzyme is part of the renin-angiotensin cascade system and converts inactive angiotensin 1 into biologically active angiotensin 2, a hormone that controls vasoconstriction and the release of aldosterone. Thus, the drug prevents narrowing of the blood vessels, lowering blood pressure and making blood circulation easier. After oral administration of the drug, benazepril hydrochloride is well absorbed in the gastrointestinal tract and metabolized in the liver to the active metabolite of benazeprilat. The maximum concentration in blood plasma is observed after 1 hour. Benazeprilat is excreted in bile and urine. Fortecor ™ tablets, according to the degree of impact on the body, are classified as moderately hazardous substances (hazard class 3 according to GOST 12.1.007).
INDICATIONS
Fortecor ™ tablets are prescribed for the treatment of heart failure in dogs.
DOSES AND METHOD OF APPLICATION
The drug is administered individually orally, once a day at a dose of 0.25 - 0.5 mg benazepril hydrochloride per 1 kg of animal weight. If necessary, a single dose of the drug can be doubled. The scheme of application of Fortecor ™ tablets is presented in the table.
FORTECOR 5mg DOSAGE:
Dog weight, kg Standard dose, tablets Increased dose, tablets
5-10 1/2 1
11-20 1 2
FORTECOR 20mg DOSAGE:
Dog weight, kg Standard dose, tablets Increased dose, tablets
21-40 1/2 1
41-80 1 2
The duration of the course of treatment depends on the condition of the animal and is determined by the attending veterinarian.
Overdose symptoms in dogs have not been established.
Avoid gaps in the introduction of the next dose of the drug, as this can lead to a decrease in therapeutic efficacy. If one dose is missed, it is necessary to continue using the drug in the same doses according to the same scheme.
SIDE EFFECTS
When using Fortecor ™ tablets in accordance with the instructions for use, side effects and complications, as a rule, are not observed.
CONTRAINDICATIONS
A contraindication to the use of Fortecor ™ tablets in dogs is aortic stenosis, as well as hypersensitivity of the animal to the components of the drug. It is not recommended to use Fortecor ™ for puppy and lactating bitches. In this case, the use of the drug is possible if the potential benefit to the animal outweighs the possible risk to the offspring, and is carried out under the supervision of the attending veterinarian.
When using Fortecor ™ tablets, it is not recommended to use potassium-sparing diuretics, calcium channel blockers, drugs containing potassium, non-steroidal anti-inflammatory, sedatives and other drugs with hypotensive effects. If necessary, the simultaneous use of these groups of drugs, you need to monitor the functional state of the kidneys, the level of potassium in the blood, pay attention to signs of hypotension (weakness, lethargy, etc.).
SPECIAL INSTRUCTIONS
No special precautions are required when disposing of an unused expired product.
PERSONAL PREVENTION MEASURES
When using Fortecor ™ tablets, you should follow the general rules of personal hygiene and safety measures provided for when working with medicines.
STORAGE CONDITIONS
Store the drug in the manufacturer's sealed packaging, separately from food and feed, in a dry, dark place at a temperature of 2 ° C to 25 ° C. Fortecor ™ should be kept out of the reach of children. The shelf life of the medicinal product, subject to storage conditions, is 3 years from the date of manufacture, after opening the package (halves of tablets) - no more than 48 hours. It is forbidden to use Fortecor ™ after the expiration date.
MANUFACTURER
"Elanco France SAS", France / "Elanco France SAS", France.
Free shipping to USA and UK
OR
Fortecor 20 mg for dogs weighing 21-80 kg, 14 tablets
COMPOSITION AND FORM OF ISSUE
Fortecor tablets 5 mg contain benazepril hydrochloride as an active ingredient - 5 mg / table. as well as auxiliary substances: microcrystalline cellulose - 19%, crospovidone - 5%, silicon colloidal anhydride - 0.5%, stearic acid - 3%, dry yeast and beef flavor additive - 60%. Fortecor ™ tablets are produced in blisters, packed in cardboard boxes.
Fortecor tablets 20 mg contain benazepril hydrochloride as an active ingredient - 20 mg / tab., As well as auxiliary substances: microcrystalline cellulose - 2.93%, crospovidone - 5%, silicon colloidal anhydride - 0.5%, stearic acid - 3% , dry yeast and beef flavor additive - 60%. Fortecor ™ tablets are produced in blisters, packed in cardboard boxes.
PHARMACOLOGICAL PROPERTIES
Fortecor ™ is an ACE inhibitor. Benazepril hydrochloride, which is part of the drug, as a result of hydrolysis forms the active metabolite benazeprilat, which inhibits the angiotensin converting enzyme (ACE). This enzyme is part of the renin-angiotensin cascade system and converts inactive angiotensin 1 into biologically active angiotensin 2, a hormone that controls vasoconstriction and the release of aldosterone. Thus, the drug prevents narrowing of the blood vessels, lowering blood pressure and making blood circulation easier. After oral administration of the drug, benazepril hydrochloride is well absorbed in the gastrointestinal tract and metabolized in the liver to the active metabolite of benazeprilat. The maximum concentration in blood plasma is observed after 1 hour. Benazeprilat is excreted in bile and urine. Fortecor ™ tablets, according to the degree of impact on the body, are classified as moderately hazardous substances (hazard class 3 according to GOST 12.1.007).
INDICATIONS
Fortecor ™ tablets are prescribed for the treatment of heart failure in dogs.
DOSES AND METHOD OF APPLICATION
The drug is administered individually orally, once a day at a dose of 0.25 - 0.5 mg benazepril hydrochloride per 1 kg of animal weight. If necessary, a single dose of the drug can be doubled. The scheme of application of Fortecor ™ tablets is presented in the table.
FORTECOR 5mg DOSAGE:
Dog weight, kg Standard dose, tablets Increased dose, tablets
5-10 1/2 1
11-20 1 2
FORTECOR 20mg DOSAGE:
Dog weight, kg Standard dose, tablets Increased dose, tablets
21-40 1/2 1
41-80 1 2
The duration of the course of treatment depends on the condition of the animal and is determined by the attending veterinarian.
Overdose symptoms in dogs have not been established.
Avoid gaps in the introduction of the next dose of the drug, as this can lead to a decrease in therapeutic efficacy. If one dose is missed, it is necessary to continue using the drug in the same doses according to the same scheme.
SIDE EFFECTS
When using Fortecor ™ tablets in accordance with the instructions for use, side effects and complications, as a rule, are not observed.
CONTRAINDICATIONS
A contraindication to the use of Fortecor ™ tablets in dogs is aortic stenosis, as well as hypersensitivity of the animal to the components of the drug. It is not recommended to use Fortecor ™ for puppy and lactating bitches. In this case, the use of the drug is possible if the potential benefit to the animal outweighs the possible risk to the offspring, and is carried out under the supervision of the attending veterinarian.
When using Fortecor ™ tablets, it is not recommended to use potassium-sparing diuretics, calcium channel blockers, drugs containing potassium, non-steroidal anti-inflammatory, sedatives and other drugs with hypotensive effects. If necessary, the simultaneous use of these groups of drugs, you need to monitor the functional state of the kidneys, the level of potassium in the blood, pay attention to signs of hypotension (weakness, lethargy, etc.).
SPECIAL INSTRUCTIONS
No special precautions are required when disposing of an unused expired product.
PERSONAL PREVENTION MEASURES
When using Fortecor ™ tablets, you should follow the general rules of personal hygiene and safety measures provided for when working with medicines.
STORAGE CONDITIONS
Store the drug in the manufacturer's sealed packaging, separately from food and feed, in a dry, dark place at a temperature of 2 ° C to 25 ° C. Fortecor ™ should be kept out of the reach of children. The shelf life of the medicinal product, subject to storage conditions, is 3 years from the date of manufacture, after opening the package (halves of tablets) - no more than 48 hours. It is forbidden to use Fortecor ™ after the expiration date.
MANUFACTURER
"Elanco France SAS", France / "Elanco France SAS", France.
Free shipping to USA and UK